`
`INVENTION REPORT AND RECORD
`
`INVENTOR(S):
`
`‘
`.
`‘
`cf‘
`.l.
`Position '/fsggsggzloc ((—)31UE:,;(,¢M:[)
`C!
`/hg/[ Q ;/L
`ECQJVQ
`Name
`/0(:){ (/2 Telephone
`‘”CDG;Q'§‘
`Home Address Q33 6"
`:)*Qh(/ISTLOZI
`Position DirC[//bf "Gaza é£{2‘)(.CJQg
`Name
`I58 mnfl fig
`;
`fWWbVflL%0CM1D
`Home Address Eh;/ID(tLfZO §WO gk[()C!
`Telephone
`Q z5:—CDc)gZ:
`I
`100/
`[Include additional names and addresses on a separate sheet.]
`
`-
`
`DESCRIPTIVE TITLE OF INVENTION:
`
`Sponsor
`
`Award Number
`
`Principal Investigator
`
`LAB/DEPARTMENT WHERE DEVELOPED:
`
`\§éGCW%Jb/Hchmlg
`
`DESCRIPTION OF INVENTION:
`
`including:
`A. State, as fully as possible, what the invention is,
`materials or components used; operative and preferred ranges of
`process parameters and concentrations of chemical compounds; and
`foreseeable uses of the invention.
`
`-
`
`«G
`Cl..C',C(;Zx!
`xlacfl @0%KJJZ&QK/
`"
`-.fl1rzfifi ;'
`
`—
`
`' 70 9-com I://mere E .
`om,c‘ cc0‘_;/..
`
`.
`
`.
`
`__
`
`rcr
`
`»
`
`W
`
`J
`»
`cl 4 fz;(j -
`4:mx@fl1(zfi%R;
`_
`~
`(C/y/;‘Lz,"£cE;gé{'1 flag ;Ga?&Zz’ é'@zcMi,
`4/a@40'
`-
`fi4fl¢<LéJgmz(,ég§ux?i§c£a f§%§e::E§;
`
`‘ \
`
`.
`
`.
`
`__
`
`‘Q
`
`—
`
`I
`
`‘
`
`Enzo Exhibit 2035
`BD v. Enzo
`Case IPR2017-00172
`
`Exhibit 2035 Page 1
`
`
`
`Exhibit 2035 Page 2
`
`
`
`Identify records which establish
`Records Supporting Invention.
`dates of conception and reduction to practice,
`including identity
`of person who prepared record and its present location. Attach
`copies if possible. Note additional supporting evidence.
`If the
`'
`invention or a significant aspect of the invention is not sup—
`ported by written records, briefly describe how the date of inven-
`tion can be established and identify earliest written record.
`
`g25){':§§QQK ~—*
`
`C. Fill in the following dates:
`
`' l. Conception
`
`2. First disclosure to another ‘
`
`2;2/
`
`8 Z
`3. First written record
`4. First experiment demonstrating the invention
`
`~52cQéi[ & 2:
`
`This invention is a(n):
`electronic circuit
`
`process
`I
`chemical compound
`‘// mixture of chemical compounds
`
`apparatus
`
`therapeutic method
`
`other
`
`(L.
`E. This invention is useful as
`5%» cfefec/" /3&4,/tones goucficzea
`
`F.
`
`The problem which this invention solves is
`O .U6(,c',Qe,e, *6, &(’/C45
`
`Qé£(CZ4Lfi%;éR«fi%g§[,
`Ce,/¢((
`
`Exhibit 2035 Page 3
`
`
`
`PRIOR ART:
`"Prior art" is any apparatus, description, publication or communi-
`cation which pertains to the area or field of the invention and
`which description, publication or communication occurred or was
`made prior to the date of conception of the invention by the in-
`ventor(s).
`The prior art most relevant to the area or field of the invention
`is:
`
`Wm WM H050/‘ 56 z .
`
`m the prior art specified in Par. A in
`This invention differs fro
`the following ways or manner:
`,6
`a>0xc:(
`/U510 uci,
`uca/(pk
`,{
`
`This invention provides the following advantages over the prior
`art specified in Par- A:
`zzetzzfif
`
`/U
`
`(1-‘(S
`
`DISCLOSURE OF INVENTION:
`on or any product derived therefrom been:
`
`Has the inventi
`
`Described in a printed publication?
`
`AD.‘
`
`Date
`
`Date
`Described in an oral presentation?
`AJC) Date
`Sold, offered for sale, or used in public?
`Are any of 1 through 3 contemplated in the near future and,
`if so, when?
`
`Exhibit 2035 Page 4
`
`
`
`5.
`
`If the answer to any of 1 through 4 is yes, provide detailed
`information,
`including copies of manuscripts, published
`articles, abstracts, etc.
`
`CONTACTS/AGREEMENTS WITH COMMERCIAL CONCERNS (include name of person
`contacted and copies of pertinent agreements)
`
`SIGNATURE OF INVENTOR ( s)
`
`Witnesses: Disclosed to and understood by me:
`
`Date:
`
`Signature:
`
`
`
`Exhibit 2035 Page 5
`
`